Antibiotic susceptibility of blood culture isolates of Enterobacteriaceae from six Norwegian hospitals 1991–1992

From August 1991 to February 1992, each of the six largest hospitals throughout Norway collected 84 to 107 consecutive blood culture isolates of Enterobacteriaceae, altogether 571 isolates. The distribution of various species and genera at the different hospitals was uniform; Escherichia coli being most prevalent (57–67%), followed by Klebsiella spp. (12–18%) and Proteus mirabilis (7–11%). Twenty‐one and 4% of E. coli isolates were resistant to ampicillin and cefuroxime, respectively, and 11% of Klebsiella isolates were cefuroxime resistant. Five Enterobacter isolates and one Citrobacter isolate were resistant to ceftazidime, and one Salmonella isolate was resistant to imipenem. All isolates were susceptible to ciprofloxacin and tobramycin. These results were compared with the antibiotic consumption in each hospital region. Although hospitals in the regions with the highest consumption of ampicillin tended to have a higher percentage of isolates resistant to this agent, no significant differences were found. There was no significant difference between hospitals regarding prevalence of cefuroxime‐resistant isolates.

[1]  A Digranes,et al.  Bloodstream infections at a Norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M. Walder,et al.  Sensitivity of 880 blood culture isolates to 24 antibiotics. , 1994, Scandinavian journal of infectious diseases.

[3]  K. Dornbusch.  Resistance to beta-lactam antibiotics and ciprofloxacin in gram-negative bacilli and staphylococci isolated from blood: a European collaborative study. European Study Group on Antibiotic Resistance. , 1990, The Journal of antimicrobial chemotherapy.

[4]  K. Shaw,et al.  Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR Study Group (European Study Group on Antibiotic Resistance). , 1990, The Journal of antimicrobial chemotherapy.

[5]  D. Reeves,et al.  Resistance of bacterial pathogens to four aminoglycosides and six other antibacterials and prevalence of aminoglycoside modifying enzymes, in 20 UK centres. , 1988, The Journal of antimicrobial chemotherapy.

[6]  S. Solomon,et al.  Health and economic impacts of antimicrobial resistance. , 1987, Reviews of infectious diseases.

[7]  P. Toivanen,et al.  Aminoglycoside resistance among blood culture isolates , 1984, Journal of clinical microbiology.

[8]  I. Phillips,et al.  Antimicrobial misuse, antibiotic policies and information resources. , 1980, The Journal of antimicrobial chemotherapy.

[9]  J. Sherris,et al.  Antibiotic sensitivity testing. Report of an international collaborative study. , 1971, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.